Figure 5

Cumulative incidence curves of late grade 2 or higher (a) genitourinary and (b) gastrointestinal toxicities for patients receiving total doses of ≥ 66 Gy (n = 226) vs. < 66 Gy (n = 66) in an equivalent dose in 2-Gy fractions (EQD2).

Cumulative incidence curves of late grade 2 or higher (a) genitourinary and (b) gastrointestinal toxicities for patients receiving total doses of ≥ 66 Gy (n = 226) vs. < 66 Gy (n = 66) in an equivalent dose in 2-Gy fractions (EQD2).